Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy

Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy

Objective Progressive pulmonary fibrosis (PPF) is the leading cause of death in systemic sclerosis (SSc). This study aimed to develop a clinical prediction nomogram using clinical and biological data to assess risk of PPF among patients receiving treatment of SSc‐related interstitial lung disease (S...

Full description

Bibliographic Details
Main Authors: Elizabeth R. Volkmann, Holly Wilhalme, Shervin Assassi, Grace Hyun J. Kim, Jonathan Goldin, Masataka Kuwana, Donald P. Tashkin, Michael D. Roth
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11598

Internet

https://doi.org/10.1002/acr2.11598

Similar Items